Clinical Trials Directory

Trials / Completed

CompletedNCT02296632

Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study

Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study and Preliminary Validation Effort

Status
Completed
Phase
Study type
Observational
Enrollment
7 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study aims to provide preliminary evidence of the validity of a sensor-based assessment of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA Enbrel patients regarding the potential of a future biosensor/PRO mHealth application. The investigators' overarching hypothesis is that if patients have better and more timely information about whether Enbrel is working, then they will become more empowered and engaged in their treatment, more curious about how it may - or may not - be working, and potentially more compliant with therapy. However, this hypothesis remains largely untested.

Detailed description

Patients with rheumatoid arthritis (RA) often endure a remitting and flaring disease-course characterized by considerable pain, stiffness, and fatigue. The social and emotional well-being of RA patients can suffer as a result. Data demonstrate that adherence to Enbrel significantly improves both functional status and health related quality of life (HRQOL) in RA patients. Yet patients prescribed Enbrel often exhibit non-adherence through early discontinuation, dose-stretching, and reduced persistence following medication "holidays". The knowledge, attitudes, and beliefs held by patients with regard to RA and Enbrel influence their perceptions of the benefits of, and barriers to, treatment. Decisions to adhere occur when combined levels of susceptibility and severity provide the motivation to act, and the perception of benefits (less barriers) indicates a path of action. A given patient's ability to follow this path of action hinges on their relative self-efficacy: the conviction that they can successfully execute a behavior required to produce an expected outcome. Landscape literature reviews conducted by CORE-UCLA suggest that interventions targeting self-efficacy offer the greatest chance of improving adherence to Enbrel. Self-efficacy plays an important mediating role in self-management activities, allowing for the adoption and maintenance of health behaviors. Many studies have identified measures of self-efficacy as significant predictors of adherence in RA patients. Additionally - though with the caveat that they are methodologically heterogeneous and of limited generalizability - a number of studies have found that interventions targeting self-efficacy can significantly improve adherence related outcomes. Seminal works in the field - including Bandura's Social Cognition Theory and Rosenstock's Health Beliefs Model - have converged on the following recommendations for behavioral interventions targeting self-efficacy: 1. Identify and reinforce the patient's past and present successes or accomplishments. 2. Direct patients to observe successful behaviors and coping mechanisms of similar others, even if this involves having them alter or expand their social network. 3. Provide positive feedback for the patient's efforts or encourage people in the patient's social network, such as family members or friends, to do this. 4. Facilitate the patient in adopting new health behaviors by ensuring that patients do not interpret incorrectly how they are feeling. Enabled by recent advances in microelectronics, signal processing algorithms, and networking capabilities, wireless health technologies hold the potential to support numerous aspects of these recommendations. Namely, motion sensors might contribute to the formation of a complete feedback loop involving self- monitoring, data presentation, and tailored messaging. Consumer Health Informatics (CHI) applications that offer complete feedback loops hold the most promise for improving self-efficacy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMotion sensors and daily online assessmentsPatients will be asked to wear motion sensors during their waking hours and complete daily Patient Reported Outcomes online assessments.

Timeline

Start date
2014-11-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2014-11-20
Last updated
2015-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02296632. Inclusion in this directory is not an endorsement.